Recently discovered sulfonamide-, acyl sulfonamide- and carboxylic acid-based endothelin antagonists

IDrugs. 2003 Mar;6(3):232-9.

Abstract

Endothelins (ET-1, 2 and 3) are 21-residue peptides with two disulfide bridges and a highly conserved carboxy terminal. ET-1, the most significant isoform, is a potent vasoconstrictor and mitogen that exerts its biological effects through binding to its two G protein-coupled receptors: ET(A) and ET(B). ET(A) receptors are expressed on vascular smooth muscle cells and mediate vasoconstrictive and proliferative responses to ET-1. ET(B) receptors are mainly located on endothelial cells where they clear ET-1 from circulation and mediate vasodilation via the release of nitric oxide. ET-1 has been associated with a variety of serious diseases such as pulmonary hypertension, heart failure, prostate cancer and renal dysfunction.

Publication types

  • Review

MeSH terms

  • Animals
  • Carboxylic Acids / chemistry*
  • Carboxylic Acids / pharmacology
  • Carboxylic Acids / therapeutic use
  • Endothelin Receptor Antagonists*
  • Humans
  • Sulfonamides / chemistry*
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use
  • Vascular Diseases / drug therapy

Substances

  • Carboxylic Acids
  • Endothelin Receptor Antagonists
  • Sulfonamides